Filing Details

Accession Number:
0001415889-23-014454
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-10-20 06:50:07
Reporting Period:
2023-10-19
Accepted Time:
2023-10-20 06:50:07
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1006281 Protalix Biotherapeutics Inc. PLX Biological Products, (No Disgnostic Substances) (2836) 650643773
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1781450 Dror Bashan C/O Protalix Biotherapeutics, Inc.
2 Snunit Street Science Park, Pob 455
Carmiel L3 2161401
President And Ceo No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-10-19 48,387 $1.40 116,387 No 4 P Direct
Common Stock Acquisiton 2023-10-19 16,129 $1.41 132,516 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct